Alternative to PSA test for prostate cancer nears $1.5M financing target
Instead of searching the blood for specific antigens that indicate the presence of cancer, a new diagnostic and prognostic test for certain cancers searches for the autoimmune signals that respond to those antigens. Armune Bioscience Inc. is developing a test based on serum autoantibodies, which the company says are more stable than antigens and may […]